Further Exploring T-Cell Acute Lymphoblastic Leukemia: Rutgers Institute Researcher Awarded V Foundation for Cancer Research Grant
October 17, 2023
October 17, 2023
NEW BRUNSWICK, New Jersey, Oct. 17 (TNSres) -- Rutgers Cancer Institute of New Jersey issued the following news:
Daniel Herranz Benito, PhD, PharmD, resident researcher at Rutgers Cancer Institute of New Jersey and RWJBarnabas Health, the state's leading cancer program and only NCI-designated Comprehensive Cancer Center and assistant professor of pharmacology at Rutgers Robert Wood Johnson Medical School, has received $800,000 from the V Foundation for Cancer Research, a premier can . . .
Daniel Herranz Benito, PhD, PharmD, resident researcher at Rutgers Cancer Institute of New Jersey and RWJBarnabas Health, the state's leading cancer program and only NCI-designated Comprehensive Cancer Center and assistant professor of pharmacology at Rutgers Robert Wood Johnson Medical School, has received $800,000 from the V Foundation for Cancer Research, a premier can . . .